GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Annexin Pharmaceuticals AB (OSTO:ANNX) » Definitions » Interest Received

Annexin Pharmaceuticals AB (OSTO:ANNX) Interest Received


View and export this data going back to 2017. Start your Free Trial

What is Annexin Pharmaceuticals AB Interest Received?

Interest Received only applicable to companies reporting Cash Flow from Operations in direct method.


Annexin Pharmaceuticals AB Business Description

Traded in Other Exchanges
N/A
Address
Norrtullsgatan 6, Stockholm, SWE, SE-113 29
Annexin Pharmaceuticals AB is a biotechnology company. It is developing biological drug candidate ANXV, a recombinant human protein Annexin A5 for treatment of various cardiovascular diseases. The company also focuses on development of ANXV for the treatment of retinal vein occlusion.